Research institutionUnited Statesdcri.org
Duke Clinical Research Institute is an academic clinical research organization based at Duke University in Durham, North Carolina. It conducts and coordinates large-scale clinical trials and provides expertise in health economic analyses for cardiovascular and other medical conditions.
The institute's main activities include trial design, data collection, statistical analysis, and regulatory affairs support. It collaborates with academic groups, pharmaceutical companies, and government agencies on projects that aim to improve patient care through evidence-based research.
Operating within the Duke University system, the DCRI has been involved in numerous high-profile studies, including independent analyses in collaboration with organizations like the TIMI Study Group. It focuses on advancing medical science rather than commercial product development.
As a leading research institution in the United States, it contributes to global clinical guidelines and holds a respected position in the field of clinical research for its rigorous methodologies and independent perspectives.
Also known as DCRI.
None yet. When a new project in the record names Duke Clinical Research Institute as owner, partner or investor, it shows here.
Data show early LDL‑C lowering with Repatha reduces major cardiovascular events and is cost‑effective for high‑risk patients without prior heart attack or stroke.
